Lineage Cell Therapeutics Inc (STU:BT3)
€ 1.11 -0.016 (-1.42%) Market Cap: 280.21 Mil Enterprise Value: 234.41 Mil PE Ratio: 0 PB Ratio: 5.93 GF Score: 78/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1